Annual Interest Expense
$317.00 K
+$29.00 K+10.07%
December 31, 2023
Summary
- As of February 7, 2025, PBLA annual interest expense is $317.00 thousand, with the most recent change of +$29.00 thousand (+10.07%) on December 31, 2023.
- During the last 3 years, PBLA annual interest expense has risen by +$300.00 thousand (+1764.71%).
- PBLA annual interest expense is now -85.55% below its all-time high of $2.19 million, reached on December 31, 2019.
Performance
PBLA Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$442.00 K
+$383.00 K+649.15%
September 30, 2024
Summary
- As of February 7, 2025, PBLA quarterly interest expense is $442.00 thousand, with the most recent change of +$383.00 thousand (+649.15%) on September 30, 2024.
- Over the past year, PBLA quarterly interest expense has increased by +$370.00 thousand (+513.89%).
- PBLA quarterly interest expense is now -65.68% below its all-time high of $1.29 million, reached on June 30, 2018.
Performance
PBLA Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$636.00 K
+$371.00 K+140.00%
September 30, 2024
Summary
- As of February 7, 2025, PBLA TTM interest expense is $636.00 thousand, with the most recent change of +$371.00 thousand (+140.00%) on September 30, 2024.
- Over the past year, PBLA TTM interest expense has increased by +$321.00 thousand (+101.90%).
- PBLA TTM interest expense is now -76.51% below its all-time high of $2.71 million, reached on June 30, 2018.
Performance
PBLA TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
PBLA Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.1% | +513.9% | +101.9% |
| 3 y3 years | +1764.7% | +333.3% | +64.8% |
| 5 y5 years | -82.5% | +333.3% | +64.8% |
PBLA Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2541.7% | at high | >+9999.0% | at high | +5200.0% |
| 5 y | 5-year | -85.5% | +2541.7% | at high | >+9999.0% | -71.0% | +5200.0% |
| alltime | all time | -85.5% | +2541.7% | -65.7% | >+9999.0% | -76.5% | +7046.1% |
Panbela Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $442.00 K(+649.2%) | $636.00 K(+140.0%) |
| Jun 2024 | - | $59.00 K(-6.3%) | $265.00 K(-4.0%) |
| Mar 2024 | - | $63.00 K(-12.5%) | $276.00 K(-12.4%) |
| Dec 2023 | $317.00 K(+10.1%) | $72.00 K(+1.4%) | $315.00 K(-25.7%) |
| Sep 2023 | - | $71.00 K(+1.4%) | $424.00 K(-3.6%) |
| Jun 2023 | - | $70.00 K(-31.4%) | $440.00 K(+14.0%) |
| Mar 2023 | - | $102.00 K(-43.6%) | $386.00 K(+34.5%) |
| Dec 2022 | $288.00 K(+2300.0%) | $181.00 K(+108.0%) | $287.00 K(+163.3%) |
| Sep 2022 | - | $87.00 K(+443.8%) | $109.00 K(+354.2%) |
| Jun 2022 | - | $16.00 K(+433.3%) | $24.00 K(+100.0%) |
| Mar 2022 | - | $3000.00(0.0%) | $12.00 K(0.0%) |
| Dec 2021 | $12.00 K(-29.4%) | $3000.00(+50.0%) | $12.00 K(-14.3%) |
| Sep 2021 | - | $2000.00(-50.0%) | $14.00 K(-6.7%) |
| Jun 2021 | - | $4000.00(+33.3%) | $15.00 K(0.0%) |
| Mar 2021 | - | $3000.00(-40.0%) | $15.00 K(-6.3%) |
| Dec 2020 | $17.00 K(-99.2%) | $5000.00(+66.7%) | $16.00 K(-11.1%) |
| Sep 2020 | - | $3000.00(-25.0%) | $18.00 K(0.0%) |
| Jun 2020 | - | $4000.00(0.0%) | $18.00 K(-98.5%) |
| Mar 2020 | - | $4000.00(-42.9%) | $1.17 M(-46.9%) |
| Dec 2019 | $2.19 M(+20.9%) | $7000.00(+133.3%) | $2.19 M(-2.0%) |
| Sep 2019 | - | $3000.00(-99.7%) | $2.24 M(0.0%) |
| Jun 2019 | - | $1.15 M(+11.5%) | $2.24 M(-5.7%) |
| Mar 2019 | - | $1.03 M(+1925.5%) | $2.38 M(+30.9%) |
| Dec 2018 | $1.81 M | $51.00 K(+1600.0%) | $1.81 M(-18.8%) |
| Sep 2018 | - | $3000.00(-99.8%) | $2.24 M(-17.4%) |
| Jun 2018 | - | $1.29 M(+172.3%) | $2.71 M(+43.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $473.00 K(+0.2%) | $1.89 M(+16.9%) |
| Dec 2017 | $1.62 M(+798.3%) | $472.00 K(-0.4%) | $1.62 M(+35.9%) |
| Sep 2017 | - | $474.00 K(+0.2%) | $1.19 M(+56.3%) |
| Jun 2017 | - | $473.00 K(+137.7%) | $762.00 K(+128.1%) |
| Mar 2017 | - | $199.00 K(+342.2%) | $334.00 K(+85.6%) |
| Dec 2016 | $180.00 K(-1.6%) | $45.00 K(0.0%) | $180.00 K(-10.4%) |
| Sep 2016 | - | $45.00 K(0.0%) | $201.00 K(+3.6%) |
| Jun 2016 | - | $45.00 K(0.0%) | $194.00 K(-0.5%) |
| Mar 2016 | - | $45.00 K(-31.8%) | $195.00 K(-1.0%) |
| Dec 2015 | $183.00 K(-0.5%) | $66.00 K(+73.7%) | $197.00 K(-1.5%) |
| Sep 2015 | - | $38.00 K(-17.4%) | $200.00 K(-1.5%) |
| Jun 2015 | - | $46.00 K(-2.1%) | $203.00 K(+22.4%) |
| Mar 2015 | - | $47.00 K(-31.9%) | $165.90 K(+29.8%) |
| Dec 2014 | $184.00 K(+412.5%) | $69.00 K(+68.3%) | $127.80 K(+88.8%) |
| Sep 2014 | - | $41.00 K(+360.7%) | $67.70 K(+90.2%) |
| Jun 2014 | - | $8900.00(0.0%) | $35.60 K(-0.3%) |
| Mar 2014 | - | $8900.00(0.0%) | $35.70 K(-0.6%) |
| Dec 2013 | $35.90 K(-0.6%) | $8900.00(0.0%) | $35.90 K(-0.6%) |
| Sep 2013 | - | $8900.00(-1.1%) | $36.10 K(-0.6%) |
| Jun 2013 | - | $9000.00(-1.1%) | $36.30 K(0.0%) |
| Mar 2013 | - | $9100.00(0.0%) | $36.30 K(+0.6%) |
| Dec 2012 | $36.10 K(+5.2%) | $9100.00(0.0%) | $36.10 K(+33.7%) |
| Sep 2012 | - | $9100.00(+1.1%) | $27.00 K(+50.8%) |
| Jun 2012 | - | $9000.00(+1.1%) | $17.90 K(+101.1%) |
| Mar 2012 | - | $8900.00 | $8900.00 |
| Dec 2011 | $34.30 K | - | - |
FAQ
- What is Panbela Therapeutics annual interest expense?
- What is the all time high annual interest expense for Panbela Therapeutics?
- What is Panbela Therapeutics annual interest expense year-on-year change?
- What is Panbela Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Panbela Therapeutics?
- What is Panbela Therapeutics quarterly interest expense year-on-year change?
- What is Panbela Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Panbela Therapeutics?
- What is Panbela Therapeutics TTM interest expense year-on-year change?
What is Panbela Therapeutics annual interest expense?
The current annual interest expense of PBLA is $317.00 K
What is the all time high annual interest expense for Panbela Therapeutics?
Panbela Therapeutics all-time high annual interest expense is $2.19 M
What is Panbela Therapeutics annual interest expense year-on-year change?
Over the past year, PBLA annual interest expense has changed by +$29.00 K (+10.07%)
What is Panbela Therapeutics quarterly interest expense?
The current quarterly interest expense of PBLA is $442.00 K
What is the all time high quarterly interest expense for Panbela Therapeutics?
Panbela Therapeutics all-time high quarterly interest expense is $1.29 M
What is Panbela Therapeutics quarterly interest expense year-on-year change?
Over the past year, PBLA quarterly interest expense has changed by +$370.00 K (+513.89%)
What is Panbela Therapeutics TTM interest expense?
The current TTM interest expense of PBLA is $636.00 K
What is the all time high TTM interest expense for Panbela Therapeutics?
Panbela Therapeutics all-time high TTM interest expense is $2.71 M
What is Panbela Therapeutics TTM interest expense year-on-year change?
Over the past year, PBLA TTM interest expense has changed by +$321.00 K (+101.90%)